Danfeng Luo
-
- Cancer-related molecular mechanisms research 3
-
- Cancer Cells and Metastasis 3
-
- Nanoparticle-Based Drug Delivery 3
-
- Cancer, Stress, Anesthesia, and Immune Response 4
-
- Inflammatory mediators and NSAID effects 4
-
- Nanoplatforms for cancer theranostics 3
-
- Cancer Research and Treatments 3
-
- Virus-based gene therapy research 2
- Cited by
- Cancer ResearchOncologyBiomaterials
- Journals
- Oncotarget (3 papers)Advanced Science (2 papers)International Journal of Nanomedicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Danfeng Luo
30 papers receiving 654 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 95
- Oncology 160
- Biomaterials 66
- Immunology 106
- Molecular Biology 328
Countries citing papers authored by Danfeng Luo
This map shows the geographic impact of Danfeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfeng Luo more than expected).
Fields of papers citing papers by Danfeng Luo
This network shows the impact of papers produced by Danfeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfeng Luo. The network helps show where Danfeng Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danfeng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 18 | |
| 5 | 2023 | 35 | |
| 6 | 2023 | 5 | |
| 7 | 2021 | 41 | |
| 8 | 2021 | 24 | |
| 9 | 2019 | 42 | |
| 10 | 2019 | 21 | |
| 11 | 2015 | 8 | |
| 12 | 2014 | 34 | |
| 13 | 2013 | 20 | |
| 14 | 2012 | 30 | |
| 15 | 2012 | 9 | |
| 16 | 2012 | 39 | |
| 17 | 2011 | 9 | |
| 18 | 2008 | 96 | |
| 19 | 2008 | 3 | |
| 20 | 2006 | 5 |
About Danfeng Luo
Danfeng Luo is a scholar working on Cancer Research, Complementary and Manual Therapy, Oncology, Biotechnology and Psychiatry and Mental health, having authored 31 papers that have together received 659 indexed citations. Recurring topics across this work include Cancer, Stress, Anesthesia, and Immune Response (4 papers), Inflammatory mediators and NSAID effects (4 papers), Cancer Cells and Metastasis (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer-related molecular mechanisms research (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Research and Treatments (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Cancer Research (95 citations), Oncology (160 citations), Biomaterials (66 citations), Immunology (106 citations) and Molecular Biology (328 citations). Danfeng Luo has collaborated with scholars based in China and United States. Frequent co-authors include Ding Ma, Xiangyi Ma, Jianfeng Zhou, Wanhua Yang, Ronghua Liu, Shixuan Wang, Rui Wei, Gang Chen, Ling Xi and Meng Li. Their work appears in journals such as Oncotarget, Advanced Science, International Journal of Nanomedicine, Clinical Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.